Ischaemic heart disease is a risk factor for renal failure after heart transplantation

International Journal of Cardiology

Volumn 123, Issue 3, 2008, Pages 358-360

  Hošková, Lenka ^a   Viklický, Ondřej ^a   Málek, Ivan ^a   Podzimková, Mariana ^a   Hegarová, Markéta ^a   Pirk, Jan ^a   Vítko, Štefan ^a   Kautzner, Josef ^a  

^a INSTITUTE FOR CLINICAL AND EXPERIMENTAL MEDICINE   (Czech Republic)

Author keywords

Coronary artery disease; Heart transplantation; Immunosuppressives; Renal dysfunction

Indexed keywords

CREATININE;

ADULT; ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; CORONARY ARTERY DISEASE; CREATININE BLOOD LEVEL; FEMALE; HEART TRANSPLANTATION; HUMAN; ISCHEMIC HEART DISEASE; KIDNEY FAILURE; KIDNEY FUNCTION; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK FACTOR; SURVIVAL; WEIGHT GAIN;

ADULT; ANALYSIS OF VARIANCE; CASE-CONTROL STUDIES; FEMALE; GRAFT REJECTION; GRAFT SURVIVAL; HEART TRANSPLANTATION; HUMANS; INCIDENCE; KIDNEY FAILURE; KIDNEY FUNCTION TESTS; LOGISTIC MODELS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; MYOCARDIAL ISCHEMIA; POSTOPERATIVE COMPLICATIONS; PROBABILITY; PROGNOSIS; REFERENCE VALUES; RETROSPECTIVE STUDIES; RISK FACTORS; SEVERITY OF ILLNESS INDEX; SURVIVAL ANALYSIS;

EID: 37349075425     PISSN: 01675273     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijcard.2006.11.187     Document Type: Article

References (8)

1. Parry G., Meiser B., and Rabago G. The clinical impact of cyclosporine nephrotoxicity in heart transplantation. Transplantation 69 (2000) S23-S26
2. Abraham K.A., McGorrian C., O'Kelly P., et al. The effect of pre-existing ischaemic heart disease on renal dysfunction in cardiac transplant recipients. Am J Transplant 2 (2002) 355-359
3. Zietse R., Balk A.H., Dorpel M.A.V.D., et al. Time course of the decline in renal function in cyclosporine-treated heart transplant recipients. Am J Nephrol 14 (1994) 1-5
4. Senechal M., Dorent R., Montcel S.T., et al. End-stage of renal failure and cardiac mortality after heart transplantation. Clin Transplant 18 (2004) 1-6
5. Kunst H., Thompson D., Hodson M., et al. Hypertension as a marker for later development of end-stage renal failure after lung and heart-lung transplantation: a cohort study. J Heart Lung Transplant 23 (2004) 1182-1188
6. O'Rourke B., Barbir M., Mitchell A.G., et al. Efficacy and safety of fluvastatin therapy for hypercholesterolemia after heart transplantation. Results of a randomised double blind placebo controlled study. Int J Cardiol 94 (2003) 235-240
7. Vítko Š., and Viklický O. Cyclosporine renal dysfunction. Transplant Proc 36 (2004) S243-S247
8. Van Gelder T., Balk A.H.M.M., Zietse R., et al. Renal insufficiency after heart transplantation: a case-control study. Nephrol Dial Transplant 13 (1998) 2322-2326